Biogen Inc. - Company & Market Research Reports

Home /
Companies /
Biogen Inc.

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 148
Immune Disorders Drugs 79
Genomics 79
Biopharmaceuticals 79
Drug Discovery 66
Oncology Drugs 53
Biotechnology 49
Pharmaceuticals 43
Musculoskeletal Disorders Drugs 41
Hematological Drugs 38
Biosimilars and Biosuperiors 30
Cardiovascular Drugs 26
Clinical Trials 26
Alzheimer's Disease Drugs 26
Allergy and Immunology 20
Infusions and Injectables 20
Optical Disorders Drugs 19
Infectious Diseases Drugs 19
Respiratory Drugs 18
Mental Disorders Drugs 18
Gastrointestinal Drugs 17
Needles and Syringes 16
E-Healthcare 14
Psoriasis Drugs 14
Pharmaceutical Manufacturing 14
Immunosuppressive Drugs 14
Neurology 13
Healthcare Services 13
Hematology 13
Drug Delivery 12
Endocrine and Metabolic Disorders Drugs 12
Lymphoma Drugs 11
Analgesics 10
Leukemia Drugs 9
Optical 9
Diagnostics 9
Liver and Kidney Disorders Drugs 9
Therapeutic Area 8
Drugs by Therapeutic Area 7
Pulmonary Medicine 7
Medical Devices 7
Company Reports 6
Enzymes 6
Hospital Management 5
Cardiology 5
Oncology 5
Proteomics 4
Neurology Devices 4
Vaccines 4
Dermatological Drugs 4
Schizophrenia Drugs 4
Pharmaceutical Intermediates 3
Generic Drugs 3
Pharmacoeconomics 3
Lung Cancer Drugs 3
Diabetes Devices 3
Stem Cells 3
Biomaterials 3
Mental Health 3
Vitamins and Dietary Supplements 3
Laboratory Equipment 3
Gastroenterology 3
In Vitro Diagnostics 2
Managed Care 2
Dermatology 2
Skin Cancer Drugs 2
Nanomedicine 2
Anxiety Drugs 2
Asthma Drugs 2
Urology and Nephrology 1
Women's Health 1
Fertility Services 1
Breast Cancer Drugs 1
Prostate Cancer Drugs 1
Colon Cancer Drugs 1
Cervical Cancer Drugs 1
Medical Imaging 1
Orthopedic Devices 1
Infectious Disease Testing 1
Computed Tomography 1
Transdermal and Transmucosal Drug Delivery 1
Biomarkers 1
Surgical Procedures 1
Contrast Media 1
Kidney Cancer Drugs 1
Antibiotics 1
Clinical Skills 1
Pediatrics 1
Anatomy 1
Allergy Drugs 1
Sexual and Reproductive Health Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

913 Results (Page 3 of 46)
- Relevance
  Sort by

Novel Antibody Therapies Market: Distribution by Type of Novel Antibody, Target Indication, Type of Therapy, Route of Administration, and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

 Report
August 2022
214 Pages
Global

From

€4768EUR$4,799USD£3,964GBP

Alzheimer's Disease Drugs - Global Strategic Business Report

 Report
November 2024
93 Pages
Global

From

€5563EUR$5,600USD£4,626GBP

Uveitis Drugs Market 2024-2028

 Report
August 2024
143 Pages
Global

From

€2484EUR$2,500USD£2,065GBP

Monoclonal Antibody Discovery and Analysis Market Report 2022-2032

 Report
December 2022
437 Pages
Global

From

€4917EUR$5,123USD£3,950GBP

Modular Manufacturing Facilities Market in Pharmaceutical and Biotechnology: Industry Trends and Global Forecasts, 2023-2035

 Report
February 2023
336 Pages
Global

From

€4768EUR$4,799USD£3,964GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Generic Musculoskeletal Disorders Drugs Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

Fibromyalgia Therapeutics Market by Drug Class, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
184 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

Idiopathic Pulmonary Fibrosis Treatment Market - Forecasts from 2024 to 2029

 Report
February 2024
114 Pages
Global

From

€4222EUR$4,250USD£3,511GBP

Alzheimer's Therapeutics Market Size, Share & Trends Analysis By Product (Cholinesterase Inhibitors, NMDA Receptor Antagonist, Combination Drug, Pipeline Drugs), By End-user, By Region, And Segment Forecasts, 2023-2030

 Report
June 2023
103 Pages
Global

From

€5911EUR$5,950USD£4,915GBP

Rare Hemophilia Factors Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028

 Report
January 2024
182 Pages
Global

From

€4471EUR$4,500USD£3,717GBP

Idiopathic Pulmonary Fibrosis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
November 2023
190 Pages
Global

From

€4471EUR$4,500USD£3,717GBP

US Cancer Biosimilar Market Opportunity, Drug Dosage, Price & Clinical Trials Insight 2026

 Report
March 2021
240 Pages
United States

From

€2980EUR$3,000USD£2,478GBP

Anti-Vascular Endothelial Growth Factor Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

 Report
May 2024
182 Pages
Global

From

€4471EUR$4,500USD£3,717GBP

Idiopathic Pulmonary Fibrosis Global Market Report 2024

 Report
February 2024
175 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

Rheumatoid Arthritis Drugs Market, Size, Share, Global Forecast 2023-2030, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis

 Report
August 2023
250 Pages
Global

From

€2474EUR$2,490USD£2,057GBP

Chronic Obstructive Pulmonary Disease (COPD) Treatment Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

Rheumatoid Arthritis Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2023 to 2031

 Report
June 2023
118 Pages
Global

From

€4471EUR$4,500USD£3,717GBP

Neuromuscular Disease Therapeutics Market 2023-2027

 Report
October 2023
163 Pages
Global

From

€2484EUR$2,500USD£2,065GBP

Antibody Drugs: Technologies and Global Markets

 Report
September 2024
156 Pages
Global

From

€4620EUR$4,650USD£3,841GBP

Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4967EUR$5,000USD£4,130GBP

913 Results (Page 3 of 46)
- 1
- 2
- 3
- 4
- 5

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.